Dave M. Johnson
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 7
- Chronic Lymphocytic Leukemia Research 7
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Gopinath Mani (2 shared papers)Dénes Marton (2 shared papers)Marc D. Feldman (2 shared papers)C. Mauli Agrawal (2 shared papers)Devang N. Patel (2 shared papers)Arturo A. Ayón (2 shared papers)Langdon L. Miller (4 shared papers)Brian Joseph Lannutti (4 shared papers)
- Journals
- Blood (5 papers)Polymer International (1 paper)Biomaterials (1 paper)New England Journal of Medicine (1 paper)Macromolecular Theory and Simulations (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Dave M. Johnson
16 papers receiving 2.2k citations
Dave M. Johnson's Hit Papers
Peers
Comparison fields: 5 of 86
- Genetics 1.6k
- Pathology and Forensic Medicine 1.1k
- Hematology 384
- Immunology 563
- Surfaces, Coatings and Films 85
Countries citing papers authored by Dave M. Johnson
This map shows the geographic impact of Dave M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave M. Johnson more than expected).
Fields of papers citing papers by Dave M. Johnson
This network shows the impact of papers produced by Dave M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave M. Johnson. The network helps show where Dave M. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Dave M. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia Hit paper breakdown → | 2014 | 1431 |
| 2 | Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia Hit paper breakdown → | 2014 | 527 |
| 3 | 2008 | 140 | |
| 4 | 2008 | 91 | |
| 5 | 2012 | 30 | |
| 6 | 2011 | 8 | |
| 7 | 2009 | 6 | |
| 8 | 2013 | 5 | |
| 9 | 2008 | 2 | |
| 10 | 2008 | 2 | |
| 11 | 2007 | 1 | |
| 12 | 2007 | 1 | |
| 13 | 2007 | 1 | |
| 14 | 2008 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2011 | 1 | |
| 17 | 2012 | 1 |
About Dave M. Johnson
Dave M. Johnson is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Organic Chemistry and Surfaces, Coatings and Films, having authored 17 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers), Multiple Myeloma Research and Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer Treatment and Pharmacology (2 papers), Dendrimers and Hyperbranched Polymers (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Genetics (1.6k citations), Pathology and Forensic Medicine (1.1k citations), Hematology (384 citations), Immunology (563 citations) and Surfaces, Coatings and Films (85 citations). Dave M. Johnson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Gopinath Mani, Dénes Marton, Marc D. Feldman, C. Mauli Agrawal, Devang N. Patel, Arturo A. Ayón, Langdon L. Miller, Brian Joseph Lannutti, Richard R. Furman and Thomas Michael Jahn. Their work appears in journals such as Blood, Polymer International, Biomaterials, New England Journal of Medicine and Macromolecular Theory and Simulations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.